ATLASNRx Pharmaceuticals (NRXP) earnings date: Nov 13, 2026
NRx Pharmaceuticals (NRXP) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.29.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NRXP
| Last price | $2.17 (-4.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the NRx Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
NRx Pharmaceuticals reports on Nov 13, 2026. One email the day before, with ATLAS’s read on NRx Pharmaceuticals. You can switch it off at any time.
Alert me before NRXP reportsFree to start. Creating an account takes under a minute.
Notify me when NRx Pharmaceuticals reports
Track NRXP free Add NRx Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
NRXP earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.29 |
| Last report | Aug 14, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -3.7% |
| Average move around a report | ±5.9% (last 4) |
| Sector | Healthcare · Biotechnology |
NRx Pharmaceuticals earnings history: last 4 reports
NRx Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.24 against an estimate of -$0.13 (-84.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.13 | -$0.24 | -84.6% | Miss | +2.7% |
| Jun 16, 2026 | $1.65 | $1.67 | +1.2% | In line | -2.5% |
| May 15, 2026 | -$0.11 | -$0.04 | +63.6% | Beat | -3.0% |
| Apr 18, 2026 | $0.39 | $0.41 | +5.1% | Beat | +15.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NRXP
See the fair value, the probability range and the earnings history of NRx Pharmaceuticals on its ATLAS page.
NRx Pharmaceuticals (NRXP) stock analysisPlans from €3.99 a month.
NRx Pharmaceuticals earnings: frequently asked questions
When does NRx Pharmaceuticals (NRXP) report earnings?
NRx Pharmaceuticals is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for NRXP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.29 per share (USD). Estimates can change before the report.
How often does NRXP beat earnings estimates?
Of its last 4 reports with a recorded result, NRx Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -3.7%. Past results do not predict the next one.
How much does NRXP move around earnings?
Over its last 4 reports the stock moved an average of 5.9% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did NRx Pharmaceuticals beat earnings estimates last quarter?
NRx Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.24 against an estimate of -$0.13 (-84.6% surprise), a miss.
How much does NRXP usually move in a day?
On a normal trading day the ATLAS model puts NRXP’s one-day range at about ±4.9%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer